Literature DB >> 33045651

The evolution of parkinsonism in primary progressive apraxia of speech: A 6-year longitudinal study.

Zeynep Idil Seckin1, Joseph R Duffy2, Edythe A Strand2, Heather M Clark2, Rene L Utianski2, Mary M Machulda3, Hugo Botha4, Farwa Ali1, Nha Trang Thu Pham5, Val J Lowe5, Jennifer L Whitwell5, Keith A Josephs6.   

Abstract

INTRODUCTION: Primary progressive apraxia of speech (PPAOS) is a neurodegenerative syndrome in which patients present with an isolated motor speech disorder. Some PPAOS patients develop parkinsonism and other features of progressive supranuclear palsy (PSP) and/or corticobasal syndrome (CBS) over time. We aimed to assess the evolution of parkinsonian characteristics in PPAOS patients who had been followed yearly for at least six years.
METHODS: From a large cohort of 46 PPAOS patients, eight were followed yearly for > 6-years in multiple NIH-funded grants. Parkinsonian and other features, including bradykinesia, tremor, rigidity, postural instability, apraxia, ocular motor function and cognition were assessed at each visit, and research criteria applied for PSP and CBS diagnosis. Neurological, speech-language test scores, and [18F]fluorodeoxyglucose PET (FDG-PET) and MRI midbrain volumes were assessed.
RESULTS: A Parkinson's plus syndrome developed in all eight patients (100%). Bradykinesia was the earliest feature, followed by rigidity and postural instability. Tremor was not a significant feature. Parkinsonism, limb apraxia and ocular motor impairment tended to develop four-to-five years after onset with some patients having slight asymmetric parkinsonism. Six patients (75%) met research criteria for probable PSP, although only one for PSP-Richardson's syndrome; three patients met criteria for possible CBS. Slightly asymmetric, left-sided, hypometabolism was observed on FDG-PET, not matching asymmetry of Parkinsonism. Midbrain hypometabolism was absent-minimal. Three patients had progressive midbrain volumes in the PSP-Richardson's syndrome range.
CONCLUSIONS: A Parkinson's plus syndrome may inevitably develop in PPAOS supporting PPAOS as an early presentation of a Parkinson's plus disorder.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Apraxia of speech; Corticobasal syndrome; PET; PSP; Parkinsonism

Year:  2020        PMID: 33045651      PMCID: PMC7769910          DOI: 10.1016/j.parkreldis.2020.09.039

Source DB:  PubMed          Journal:  Parkinsonism Relat Disord        ISSN: 1353-8020            Impact factor:   4.891


  25 in total

1.  Frontal Assessment Battery in Parkinson's Disease: Validity and Morphological Correlates.

Authors:  Ondrej Bezdicek; Filip Růžička; Adela Fendrych Mazancova; Jan Roth; Pavel Dušek; Karsten Mueller; Evžen Růžička; Robert Jech
Journal:  J Int Neuropsychol Soc       Date:  2017-07-18       Impact factor: 2.892

2.  The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment.

Authors:  Ziad S Nasreddine; Natalie A Phillips; Valérie Bédirian; Simon Charbonneau; Victor Whitehead; Isabelle Collin; Jeffrey L Cummings; Howard Chertkow
Journal:  J Am Geriatr Soc       Date:  2005-04       Impact factor: 5.562

3.  Clinical and imaging progression over 10 years in a patient with primary progressive apraxia of speech and autopsy-confirmed corticobasal degeneration.

Authors:  Katerina A Tetzloff; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Sarah M Boland; Rene L Utianski; Hugo Botha; Matthew L Senjem; Christopher G Schwarz; Keith A Josephs; Jennifer L Whitwell
Journal:  Neurocase       Date:  2018-05-25       Impact factor: 0.881

4.  Sample size calculations for clinical trials targeting tauopathies: a new potential disease target.

Authors:  Jennifer L Whitwell; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Nirubol Tosakulwong; Stephen D Weigand; Matthew L Senjem; Anthony J Spychalla; Jeffrey L Gunter; Ronald C Petersen; Clifford R Jack; Keith A Josephs
Journal:  J Neurol       Date:  2015-06-17       Impact factor: 4.849

5.  The FAB: a Frontal Assessment Battery at bedside.

Authors:  B Dubois; A Slachevsky; I Litvan; B Pillon
Journal:  Neurology       Date:  2000-12-12       Impact factor: 9.910

6.  Neuroanatomical correlates of the progressive supranuclear palsy corticobasal syndrome hybrid.

Authors:  K A Josephs; S D Z Eggers; C R Jack; J L Whitwell
Journal:  Eur J Neurol       Date:  2012-04-23       Impact factor: 6.089

7.  Clinicopathological and imaging correlates of progressive aphasia and apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edyth A Strand; Jennifer L Whitwell; Kenneth F Layton; Joseph E Parisi; Mary F Hauser; Robert J Witte; Bradley F Boeve; David S Knopman; Dennis W Dickson; Clifford R Jack; Ronald C Petersen
Journal:  Brain       Date:  2006-04-13       Impact factor: 13.501

8.  Clinical Progression in Four Cases of Primary Progressive Apraxia of Speech.

Authors:  Rene L Utianski; Joseph R Duffy; Heather M Clark; Edythe A Strand; Sarah M Boland; Mary M Machulda; Jennifer L Whitwell; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2018-11-21       Impact factor: 2.408

9.  Criteria for the diagnosis of corticobasal degeneration.

Authors:  Melissa J Armstrong; Irene Litvan; Anthony E Lang; Thomas H Bak; Kailash P Bhatia; Barbara Borroni; Adam L Boxer; Dennis W Dickson; Murray Grossman; Mark Hallett; Keith A Josephs; Andrew Kertesz; Suzee E Lee; Bruce L Miller; Stephen G Reich; David E Riley; Eduardo Tolosa; Alexander I Tröster; Marie Vidailhet; William J Weiner
Journal:  Neurology       Date:  2013-01-29       Impact factor: 9.910

10.  Characterizing a neurodegenerative syndrome: primary progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Edythe A Strand; Mary M Machulda; Matthew L Senjem; Ankit V Master; Val J Lowe; Clifford R Jack; Jennifer L Whitwell
Journal:  Brain       Date:  2012-03-01       Impact factor: 13.501

View more
  4 in total

1.  Autopsy Validation of Progressive Supranuclear Palsy-Predominant Speech/Language Disorder Criteria.

Authors:  Fatma Ozlem Hokelekli; Joseph R Duffy; Heather M Clark; Rene L Utianski; Hugo Botha; Farwa Ali; Julie A Stierwalt; Mary M Machulda; R Ross Reichard; Dennis W Dickson; Jennifer L Whitwell; Keith A Josephs
Journal:  Mov Disord       Date:  2021-10-10       Impact factor: 10.338

2.  Assessing Change in Communication Limitations in Primary Progressive Apraxia of Speech and Aphasia: A 1-Year Follow-Up Study.

Authors:  Rene L Utianski; Peter R Martin; Joseph R Duffy; Hugo Botha; Heather M Clark; Keith A Josephs
Journal:  Am J Speech Lang Pathol       Date:  2021-09-07       Impact factor: 4.018

3.  Primary Progressive Apraxia of Speech: From Recognition to Diagnosis and Care.

Authors:  Joseph R Duffy; Rene L Utianski; Keith A Josephs
Journal:  Aphasiology       Date:  2020-07-07       Impact factor: 2.773

4.  A molecular pathology, neurobiology, biochemical, genetic and neuroimaging study of progressive apraxia of speech.

Authors:  Keith A Josephs; Joseph R Duffy; Heather M Clark; Rene L Utianski; Edythe A Strand; Mary M Machulda; Hugo Botha; Peter R Martin; Nha Trang Thu Pham; Julie Stierwalt; Farwa Ali; Marina Buciuc; Matthew Baker; Cristhoper H Fernandez De Castro; Anthony J Spychalla; Christopher G Schwarz; Robert I Reid; Matthew L Senjem; Clifford R Jack; Val J Lowe; Eileen H Bigio; Ross R Reichard; Eric J Polley; Nilufer Ertekin-Taner; Rosa Rademakers; Michael A DeTure; Owen A Ross; Dennis W Dickson; Jennifer L Whitwell
Journal:  Nat Commun       Date:  2021-06-08       Impact factor: 17.694

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.